134 related articles for article (PubMed ID: 8197755)
1. [Determination of serum pepsinogen I and II for assessment of gastroduodenal tolerance of S(+) ibuprofen].
Kullich W; Wallner H; Klein G
Wien Klin Wochenschr; 1994; 106(7):208-11. PubMed ID: 8197755
[TBL] [Abstract][Full Text] [Related]
2. [Value of pepsinogen I in serum as a screening method for early detection of gastroduodenal lesions and follow-up in therapy with non-steroidal antirheumatic drugs].
Kullich W; Pöllmann G; Zmerekar C; Klein G
Z Rheumatol; 1991; 50(1):39-45. PubMed ID: 2058321
[TBL] [Abstract][Full Text] [Related]
3. [Gastroduodenal tolerance and clinical effectiveness of therapy with lonazolac-calcium in rheumatic diseases].
Kullich W; Fromme K; Klein G
Wien Med Wochenschr; 1996; 146(17):459-64. PubMed ID: 9045528
[TBL] [Abstract][Full Text] [Related]
4. [Changes in the serum pepsinogen level during therapy with acemtacin retard as a measure of gastroduodenal tolerance].
Kullich W; Klein G
Wien Med Wochenschr; 1991; 141(15):331-5. PubMed ID: 1949833
[TBL] [Abstract][Full Text] [Related]
5. Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population.
Agréus L; Storskrubb T; Aro P; Ronkainen J; Talley NJ; Sipponen P
Scand J Gastroenterol; 2009; 44(5):564-70. PubMed ID: 19263272
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of piroxicam and ibuprofen in rheumatoid arthritis.
Alam MN; Kabir MZ
Bangladesh Med Res Counc Bull; 1983 Dec; 9(2):54-9. PubMed ID: 6609700
[TBL] [Abstract][Full Text] [Related]
7. Lansoprazole elevates the ratio of serum pepsinogen I v.s. pepsinogen II.
Matsukawa Y; Nishinarita S; Kaneko M; Takei M; Murakami M; Horie T; Kawamura F; Arakawa Y; Kuwayama H; Kurosaka H
Int J Clin Pharmacol Res; 1997; 17(4):127-32. PubMed ID: 9526173
[TBL] [Abstract][Full Text] [Related]
8. Serum pepsinogen I and gastrin in peptic ulcer patients using nonsteroidal anti-inflammatory drugs.
Kemppainen H; Räihä I; Sourander L
Hepatogastroenterology; 1997; 44(16):1143-6. PubMed ID: 9261614
[TBL] [Abstract][Full Text] [Related]
9. [Nizatidine in therapy and prevention of non-steroidal anti-rheumatic drug-induced ulcers in rheumatic patients].
Simon B; Leucht U; Amon I; Brandau J; Müller P
Z Gastroenterol; 1993 Jun; 31(6):395-400. PubMed ID: 8212757
[TBL] [Abstract][Full Text] [Related]
10. Pepsinogens I and II: purification from gastric mucosa and radioimmunoassay in serum.
Samloff IM
Gastroenterology; 1982 Jan; 82(1):26-33. PubMed ID: 7053333
[TBL] [Abstract][Full Text] [Related]
11. Effect of Helicobacter pylori eradication on gastric histology, serum gastrin and pepsinogen I levels, and gastric emptying in patients with gastric ulcer.
Maconi G; Lazzaroni M; Sangaletti O; Bargiggia S; Vago L; Bianchi Porro G
Am J Gastroenterol; 1997 Oct; 92(10):1844-8. PubMed ID: 9382049
[TBL] [Abstract][Full Text] [Related]
12. Influence of lornoxicam on serum pepsinogen levels.
Kullich W; Klein G; Pöllmann G
Postgrad Med J; 1990; 66 Suppl 4():S46-8. PubMed ID: 2149454
[TBL] [Abstract][Full Text] [Related]
13. [Cigarette smoking and group I pepsinogen levels. Study in a normal population].
Germanà B; Di Mario F; Vianello F; Dotto P; Faggian D; Plebani M; Saggioro A; Naccarato R
G Clin Med; 1990; 71(8-9):493-5. PubMed ID: 2279624
[TBL] [Abstract][Full Text] [Related]
14. Valdecoxib is as effective as diclofenac in the management of rheumatoid arthritis with a lower incidence of gastroduodenal ulcers: results of a 26-week trial.
Pavelka K; Recker DP; Verburg KM
Rheumatology (Oxford); 2003 Oct; 42(10):1207-15. PubMed ID: 12810937
[TBL] [Abstract][Full Text] [Related]
15. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
[TBL] [Abstract][Full Text] [Related]
16. Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine.
Miyake K; Ueki N; Suzuki K; Shinji Y; Kusunoki M; Hiratsuka T; Nishigaki H; Tatsuguchi A; Futagami S; Wada K; Tsukui T; Nakajima A; Yoshino S; Sakamoto C
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():67-72. PubMed ID: 15943850
[TBL] [Abstract][Full Text] [Related]
17. Defining patients at risk of non-steroidal anti-inflammatory drug gastropathy.
Russell RI
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S14-8. PubMed ID: 10379464
[TBL] [Abstract][Full Text] [Related]
18. Observations on the gastric mucosa of rheumatic patients before and after ibuprofen administration as studied by the pentagastrin test, endoscopy, and light and electron microscopy.
Teixeira AV; Abrunhosa R; Poças L
J Int Med Res; 1977; 5(4):243-52. PubMed ID: 881096
[TBL] [Abstract][Full Text] [Related]
19. Rates of serious gastrointestinal events from low dose use of acetylsalicylic acid, acetaminophen, and ibuprofen in patients with osteoarthritis and rheumatoid arthritis.
Fries JF; Bruce B
J Rheumatol; 2003 Oct; 30(10):2226-33. PubMed ID: 14528521
[TBL] [Abstract][Full Text] [Related]
20. Ibuprofen as an over-the-counter drug: is there a risk for renal injury?
Mann JF; Goerig M; Brune K; Luft FC
Clin Nephrol; 1993 Jan; 39(1):1-6. PubMed ID: 8428401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
